Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use

Keywords

Vardenafil, Tadalafil, Phosphodiesterase, Cyclic nucleotide, Isozyme

References

• Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase.A.G. da Silva, Luiz Telmo Auler — 1997
• Phosphodiesterase 7A-Deficient Mice Have Functional T CellsHaider A. Khan — 2003
• Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiologyБ. М. Кершенгольц, В. В. Аньшакова — 2005
• Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme.W. J. Thompson, Wesley L. Terasaki, Paul M. Epstein — 1979
• Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants.Peng Wang, Ping Wu, Robert W. Egan — 2003
• Generation of PDE4 knockout mice by gene targeting.S.-L. Catherine Jin, Anne M. Latour, Marco Conti — 2005
• Purification of calmodulin-stimulated cyclic nucleotide phosphodiesterase by monoclonal antibody affinity chromatography.R. Scott Hansen, Harry Charbonneau, Joseph A. Beavo — 1988
• Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transporters.H. Francis Sharron — 2005
• 血小板のcyclic nucleotide (血小板)弘義 日高, 富子 浅野 — 1976
• Calmodulin and signal transductionL. Eldik, D. Watterson — 1998
• Isolation and characterizationKursad Turksen — 2006
• Characterization of a novel cGMP binding protein from rat lung.Sharron H. Francis, Thomas Lincoln, Jackie D. Corbin — 1980
• Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains.Keizo Yuasa, Yutaka Kanoh, Katsuzumi Okumura — 2001
• Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs).Dawn M. Juilfs, Scott H. Soderling, Fiona Burns — 1999
• Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers.Donna Donigi Gale, Linda J Landells, Domenico Spina — 2002
• Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae.Tamar Michaeli, Timothy J. Bloom, Timothy J. Martins — 1993
• A-Kinase Anchoring Proteins Interact with Phosphodiesterases in T Lymphocyte Cell Lines1Angela L. Asirvatham, Sarah G. Galligan, Robynn V. Schillace — 2004
• Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin TMadiha Hassan, Amal F Ketat — 2005
• Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A.Kotomi Fujishige, Jun Kotera, Kenji Omori — 1999
• TCR- and CD28-Mediated Recruitment of Phosphodiesterase 4 to Lipid Rafts Potentiates TCR Signaling1Hilde Abrahamsen, George S. Baillie, Jacob Ngai — 2004

Cited by

• Fosfodiesterasas del AMPc y del GMPc en el cerebro: Expresión en procesos neuroinflamatorios y neurodegenerativosElisabet Reyes Irisarri — 2007
• Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.Sharron H. Francis, Konjeti R. Sekhar, Hengming Ke — 2011
• Targeting Phosphodiesterases in Anti-platelet TherapyMatthew T. Rondina, Andrew S. Weyrich — 2012
• Constitutive Phosphodiesterase Activity Restricts Spontaneous Beating Rate of Cardiac Pacemaker Cells by Suppressing Local Ca2+ ReleasesJ.C. McCaslin — 2008
• Phosphodiesterases in the central nervous system.Paul Philip Abrigo — 2009
• The role of calcium in the regulation of renin secretion.章仁 久保田, 千香子 柳澤, 雅義 押見 — 2010
• Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF.Mairie de Roiffieux — 2010
• Myocardial and Reproductive System Toxicity of SCH 351591, a Selective Phosphodiesterase-4 Inhibitor, in CD-1 MiceDavid Ferraiolo, Dennis Gilbert, Nickilyn Lynch — 2010
• Absence of MSY2 in Mouse Oocytes Perturbs Oocyte Growth and Maturation, RNA Stability, and the Transcriptome1喜美 大和田 — 2011
• The GAF-tandem domain of phosphodiesterase 5 as a potential drug target.Γεωργία Κωστοπούλου — 2011
• Effect of vardenafil on semen parameters in infertile men: A pilot study evaluating short-term treatmentRocco Rago, Paola Salacone, Luisa Caponecchia — 2012
• Intramolecular signaling in tandem-GAF domains from PDE5 and PDE10 studied with a cyanobacterial adenylyl cyclase reporter.Antonio Estache — 2012
• Potential therapeutic applications of phosphodiesterase inhibition in prostate cancerJane. Coad — 2013
• Newer agents in antiplatelet therapy: a reviewJosepa Gómez Bruguera — 2012
• Cellular Targets of Nitric Oxide in the Hippocampus紀彦 石川, 誠 小田, 宣男 常塚 — 2013
• Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.Delphine Mika, P Bobin, Martine Pomérance — 2013
• The Role of Cyclic Nucleotide Signaling Pathways in Cancer: Targets for Prevention and Treatment良弘 城戸, 道雄 小川, 均 塩崎 — 2014
• Zaprinast impairs spatial memory by increasing PDE5 expression in the rat hippocampus.Marielle Ernould-Gandouet — 2015
• Development of computational models of cAMP signaling.Antoni María Castells Oliveres — 2015
• Inhibition of breast cancer cell migration by activation of cAMP signalingSantiago Bruno Olmo García — 2015

Related papers

• Tadalafil and vardenafilKatherine Neumeyer, Peter Kirkpatrick — 2004
• Phosphodiesterase 5 inhibitors in male sexual dysfunctionAndrea Küthe — 2003
• PIHI7 EVALUATION OF TADALAFIL AND VARDENAFIL TREATMENT PATTERNS IN PRIOR SILDENAFIL USERSJohn D. Harriett, Trent McLaughlin, Soraya Burhani — 2005
• Review: PDE-5 inhibitors — a summaryStuart Hood, Mike Kirby — 2004
• High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patientsJames L. Weeks, Roya Zoraghi, Alfreda Beasley — 2005
• PS-08-012 Is tadalafil superior versus vardenafil in management of erectile dysfunction?K. Drasa, E. Dani, Висар Малај — 2016
• [Phosphodiesterase inhibitors: effectiveness and new applications].Mels F. van Driel — 2006
• Comparison of phosphodiesterase type 5 (PDE5) inhibitorsPamela J. Wright — 2006
• Concomitant use of paroxetine and pimozide contraindicated&NA; — 2005
• 536Rechallenging non-responders to tadalafil and vardenafil: A real-life studyKonstantinos Hatzimouratidis, K. Moysidis, Athanasios Bekos — 2005